LC-MI-3

N/A

Report date: 2024/05/11 18:36:12
NME

Base Information

Drug NameLC-MI-3
Drug Alias NameLC-MI-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-1 receptor-associated kinase 4 degraders
TargetsInterleukin-1 receptor-associated kinase 4
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou Medical College
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Medical College
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A